KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Retained Earnings (2019 - 2025)

Hims & Hers Health's Retained Earnings history spans 7 years, with the latest figure at -$113.8 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 35014.81% year-over-year to -$113.8 million; the TTM value through Dec 2025 reached -$113.8 million, down 35014.81%, while the annual FY2025 figure was -$113.8 million, 35014.81% down from the prior year.
  • Retained Earnings for Q4 2025 was -$113.8 million at Hims & Hers Health, up from -$134.4 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $822000.0 in Q2 2025 and bottomed at -$369.4 million in Q3 2023.
  • The 5-year median for Retained Earnings is -$124.1 million (2025), against an average of -$153.1 million.
  • The largest annual shift saw Retained Earnings plummeted 787105.0% in 2022 before it surged 589.29% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$137000.0 in 2021, then plummeted by 102.19% to -$277000.0 in 2022, then tumbled by 132815.16% to -$368.2 million in 2023, then surged by 99.91% to -$324000.0 in 2024, then plummeted by 35014.81% to -$113.8 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Retained Earnings are -$113.8 million (Q4 2025), -$134.4 million (Q3 2025), and $822000.0 (Q2 2025).